Epigenome-wide DNA methylation assay reveals placental epigenetic markers for noninvasive fetal single-nucleotide polymorphism genotyping in maternal plasma

Transfusion

Volumn 54, Issue 10, 2014, Pages 2523-2533

  Ou, Xueling ^a   Wang, Huan ^b   Qu, Dongyang ^a   Chen, Yongzhen ^c   Gao, Jun ^b   Sun, Hongyu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BISULFITE; METHYLATION SENSITIVE RESTRICTION ENZYME; MOLECULAR MARKER; PROTEIN; PROTEIN ACTB; PROTEIN CHST11; PROTEIN PSMB8; PROTEIN SKI; RESTRICTION ENDONUCLEASE; TESTIS DETERMINING FACTOR; UNCLASSIFIED DRUG; GENETIC MARKER;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION ASSAY; EPIGENETICS; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GENE SEQUENCE; GENETIC MARKER; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MATERNAL BLOOD; MATERNAL PLASMA; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PROMOTER REGION; SECOND TRIMESTER PREGNANCY; SINGLE NUCLEOTIDE POLYMORPHISM; THIRD TRIMESTER PREGNANCY; DNA METHYLATION; DNA MICROARRAY; GENETIC EPIGENESIS; GENETIC SCREENING; GENOTYPING TECHNIQUE; METABOLISM; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FETUS; GENETIC MARKERS; GENETIC TESTING; GENOTYPING TECHNIQUES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84908086526     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12659     Document Type: Article

References (37)

1. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487.
2. Galbiati S, Smid M, Gambini D, et al. Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 2005; 117: 243-248.
3. Lo YM, Zhang J, Leung TN, et al. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999; 64: 218-224.
4. Chiu RW, Lo YM,. Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med 2011; 16: 88-93.
5. Kolialexi A, Tounta G, Apostolou P, et al. Early non-invasive detection of fetal Y chromosome sequences in maternal plasma using multiplex PCR. Eur J Obstet Gynecol Reprod Biol 2012; 161: 34-37.
6. Deng Z, Wu G, Li Q, et al. Noninvasive genotyping of 9 Y-chromosome specific STR loci using circulatory fetal DNA in maternal plasma by multiplex PCR. Prenat Diagn 2006; 26: 362-368.
7. Wagner J, Dzijan S, Marjanovic D, et al. Non-invasive prenatal paternity testing from maternal blood. Int J Legal Med 2009; 123: 75-79.
8. Lim JH, Park SY, Kim SY, et al. Effective detection of fetal sex using circulating fetal DNA in first-trimester maternal plasma. FASEB J 2012; 26: 250-258.
9. Chim SS, Tong YK, Chiu RW, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A 2005; 102: 14753-14758.
10. Chan KC, Ding C, Gerovassili A, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006; 52: 2211-2218.
11. Grunau C, Clark SJ, Rosenthal A,. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001; 29: E65.
12. Du Y, Zhang J, Wang H, et al. Hypomethylated DSCR4 is a placenta-derived epigenetic marker for trisomy 21. Prenat Diagn 2011; 31: 207-214.
13. Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992; 89: 1827-1831.
14. von Kanel T, Gerber D, Schaller A, et al. Quantitative 1-step DNA methylation analysis with native genomic DNA as template. Clin Chem 2010; 56: 1098-1106.
15. Glossop JR, Nixon NB, Emes RD, et al. Epigenome-wide profiling identifies significant differences in DNA methylation between matched-pairs of T- and B-lymphocytes from healthy individuals. Epigenetics 2013; 8: 1188-1197.
16. Bibikova M, Le J, Barnes B, et al. Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics 2009; 1: 177-200.
17. Tsui DW, Lam YM, Lee WS, et al. Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome. Plos One 2010; 5: e15069.
18. Chan KC, Zhang J, Hui AB, et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004; 50: 88-92.
19. Chavan-Gautam P, Sundrani D, Pisal H, et al. Gestation-dependent changes in human placental global DNA methylation levels. Mol Reprod Dev 2011; 78: 150.
20. Chim SS, Jin S, Lee TY, et al. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. Clin Chem 2008; 54: 500-511.
21. Papageorgiou EA, Fiegler H, Rakyan V, et al. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol 2009; 174: 1609-1618.
22. Chu T, Burke B, Bunce K, et al. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease. Prenat Diagn 2009; 29: 1020-1030.
23. Tong YK, Jin S, Chiu RW, et al. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem 2010; 56: 90-98.
24. Yin A, Zhang X, Wu J, et al. Screening significantly hypermethylated genes in fetal tissues compared with maternal blood using a methylated-CpG island recovery assay-based microarray. BMC Med Genomics 2012; 5: 26.
25. Lun FM, Chiu RW, Sun K, et al. Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. Clin Chem 2013; 59: 1583-1594.
26. Alberry M, Maddocks D, Jones M, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007; 27: 415-418.
27. Zhao F, Wang J, Liu R, et al. Quantification and application of the placental epigenetic signature of the RASSF1A gene in maternal plasma. Prenat Diagn 2010; 30: 778-782.
28. Tsui DW, Chan KC, Chim SS, et al. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn 2007; 27: 1212-1218.
29. Ou X, Gao J, Chen Y, et al. Detecting hypermethylated fetal RASSF1A sequences in maternal plasma: implications for noninvasive paternity testing in pregnancy. Transfusion 2013; 53: 1856-1858.
30. Guo X, Bayliss P, Damewood M, et al. A noninvasive test to determine paternity in pregnancy. N Engl J Med 2012; 366: 1743-1745.
31. Ryan A, Baner J, Demko Z, et al. Informatics-based, highly accurate, noninvasive prenatal paternity testing. Genet Med 2013; 15: 473-477.
32. Gill P,. An assessment of the utility of single nucleotide polymorphisms (SNPs) for forensic purposes. Int J Legal Med 2001; 114: 204-210.
33. Agarwal AK, Xing C, DeMartino GN, et al. PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome. Am J Hum Genet 2010; 87: 866-872.
34. Kitamura A, Maekawa Y, Uehara H, et al. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J Clin Invest 2011; 121: 4150-4160.
35. Li Y, Zimmermann B, Rusterholz C, et al. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNApolymorphisms. Clin Chem 2004; 50: 1002-1011.
36. Clausen FB, Krog GR, Rieneck K, et al. Improvement in fetal DNA extraction from maternal plasma. Evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit. Prenat Diagn 2007; 27: 6-10.
37. Legler TJ, Liu Z, Mavrou A, et al. Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn 2007; 27: 824-829.